MeSH D008415 - mastocytosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009372:Connective tissue neoplasms
0 Companies
0 Drugs
Success rate
D000090362:Mast cell activation disorders
0 Companies
0 Drugs
Success rate
D008415:
Mastocytosis
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cromolyn | Cromolyn | 2000-01-18 | |||
| Mylan | Cromolyn | Gastrocrom | 1996-02-29 | |||
| Perrigo | Cromolyn | Cromolyn | 2001-12-12 | |||
| Sandoz | Cromolyn | Cromolyn | 1999-06-16 | |||
| Novartis | Midostaurin | Rydapt | 2017-09-18 | |||
| Sanofi | Cromolyn | Intal | 1982-01-01 | |||
| UCB | Cromolyn | Gastrocrom | 1989-12-22 | |||
| King Pharmaceuticals | Cromolyn | Cromoptic | 1999-04-27 | |||
| Cromolyn | Intal | 1982-05-28 | ||||
| Bausch Health Companies | Cromolyn | Crolom | 1995-01-30 | |||
| Cromolyn | Cromolyn | 2000-12-21 | ||||
| Allergan | Cromolyn | Opticrom | 1984-10-03 | |||
| Cromolyn | Cromolyn | 2001-07-26 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
10%1/10
Phase 3
67%2/3
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use